UAE Medical Tourism Market Size, Share & Forecast, By Treatment Type, Patient Origin & Care Setting, 2026-2032

The UAE Medical Tourism Market was valued at USD 435 million in 2025 on a direct medical-service revenue basis. The definition includes healthcare revenue generated from non-resident international patients travelling to the UAE for planned treatment, diagnostics, elective procedures, complex surgery and rehabilitation. It excludes airline tickets, general hotel spending and unrelated tourism expenditure. Dubai is the largest contributor, anchored by 691,478 health tourists in 2023, while Abu Dhabi contributes a higher-value mix of complex tertiary and specialty care.

The market is projected to grow at a 9.40% CAGR from 2025 to 2032, reaching approximately USD 816 million in direct medical-service revenue by 2032. Patient volume is modeled to grow near 8.0% annually, with the remaining value expansion coming from gradual improvement in average treatment yield. Higher-acuity tertiary care, international referral partnerships, medical-visa digitization, cross-border teleconsultation and continued hospital capacity development support the outlook, while regional pricing competition prevents the forecast from assuming double-digit expansion indefinitely.

The strongest profit-pool shift is expected from low-ticket outpatient medical tourism toward complex surgical care, advanced diagnostics and coordinated tertiary treatment. Dentistry and dermatology remain large traffic generators, but cardiovascular, oncology, orthopaedic, fertility and other complex procedures produce higher revenue per patient and better utilization of expensive hospital infrastructure. Cleveland Clinic Abu Dhabi's 35% international-patient growth in 2024 and Abu Dhabi's Visiting Physician Programme demonstrate growing demand for specialized cases that previously might have been referred outside the region.

The principal commercial risk is intense competition from established and lower-cost treatment destinations while UAE providers also face rapidly rising domestic utilization. Türkiye generated approximately USD 3.02 billion from 1.40 million health tourists in 2025, while Jordan attracted around 230,000 foreign patients and nearly USD 1 billion in revenue. At the same time, Dubai health-insurance claims reached approximately 49.6 million in 2025. Providers therefore need to protect resident capacity while maintaining internationally competitive pricing, clinical outcomes and patient acquisition costs.

The UAE ranks as a significant but not the largest regional destination. In the selected peer set, Türkiye and Jordan are larger by medical-tourism revenue, while the UAE offers a stronger combination of premium tourism infrastructure, Gulf connectivity, sophisticated tertiary hospitals and digitally coordinated patient services. Qatar is smaller today but is forecast by external research to expand rapidly, and Saudi Arabia is investing aggressively in healthcare capacity. The UAE's competitive position therefore depends on converting its established visitor base into higher-value medical demand and referral contracts.

The most important drivers are international visitor scale, healthcare capacity, dedicated health-tourism infrastructure and improved cross-border patient coordination. Dubai received 19.59 million international overnight visitors in 2025, providing an unusually large pool for elective and preventive healthcare conversion. Its healthcare system reached roughly 5,800 licensed facilities in 2025, while the official DXH ecosystem includes more than 100 participating facilities. Abu Dhabi adds specialized tertiary capacity and is increasingly integrating international patient pathways through digital platforms and airline-provider partnerships.